Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Dec 13, 2021 · 10-Q · 43 days after period end · 0001214659-21-013025
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Net Income | -$3.60M | -$1.35M |
| EPS Diluted | -$0.04 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Oct 31, 2021 · filed Dec 13, 2021 · 43 d after period end
